Betashares FTSE100 ETF (ASX:F100)
13.97
-0.07 (-0.50%)
Aug 1, 2025, 3:20 PM AEST
-0.50% (1Y)
Assets | 409.92M |
Expense Ratio | 0.45% |
PE Ratio | 17.73 |
Dividend (ttm) | 0.47 |
Dividend Yield | 3.33% |
Ex-Dividend Date | Jul 1, 2025 |
Payout Frequency | Semi-Annual |
Payout Ratio | 59.32% |
1-Year Return | +16.51% |
Volume | 119,561 |
Open | 14.04 |
Previous Close | 14.04 |
Day's Range | 13.97 - 14.04 |
52-Week Low | 11.80 |
52-Week High | 14.26 |
Beta | 0.50 |
Holdings | 105 |
Inception Date | Jul 12, 2019 |
About F100
BetaShares FTSE 100 ETF provides access to a recognized benchmark of blue-chip companies listed in the United Kingdom. Its investment objective is to track the price and income performance of the FTSE 100 Index. The company is headquartered in Sydney, Australia.
Asset Class Equity
Category Total Market
Stock Exchange Australian Securities Exchange
Ticker Symbol F100
Provider BetaShares
Index Tracked FTSE 100 Index
Performance
F100 had a total return of 16.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.02%.
Top 10 Holdings
45.70% of assetsName | Symbol | Weight |
---|---|---|
AstraZeneca PLC | AZN | 7.60% |
HSBC Holdings plc | HSBA | 7.29% |
Shell plc | SHEL | 7.26% |
Unilever PLC | ULVR | 4.86% |
Rolls-Royce Holdings plc | RR | 4.07% |
British American Tobacco p.l.c. | BATS | 3.50% |
RELX PLC | REL | 3.24% |
BP p.l.c. | BP | 2.89% |
GSK plc | GSK | 2.57% |
BAE Systems plc | BA | 2.43% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jul 1, 2025 | 0.30574 AUD | Jul 16, 2025 |
Jan 2, 2025 | 0.16167 AUD | Jan 17, 2025 |
Jul 1, 2024 | 0.23796 AUD | Jul 16, 2024 |
Jan 2, 2024 | 0.19532 AUD | Jan 17, 2024 |
Jul 3, 2023 | 0.17478 AUD | Jul 18, 2023 |
Jan 3, 2023 | 0.16354 AUD | Jan 18, 2023 |